- Previous Close
8.11 - Open
7.70 - Bid --
- Ask --
- Day's Range
7.70 - 8.00 - 52 Week Range
6.51 - 24.95 - Volume
59,763 - Avg. Volume
160,592 - Market Cap (intraday)
1.174B - Beta (5Y Monthly) 0.57
- PE Ratio (TTM)
-- - EPS (TTM)
-7.42 - Earnings Date May 28, 2025 - Jun 2, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 1, 2019
- 1y Target Est
--
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, wearables, DICOM devices, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
www.takesolutions.comRecent News: TAKE.NS
View MorePerformance Overview: TAKE.NS
Trailing total returns as of 4/7/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TAKE.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TAKE.NS
View MoreValuation Measures
Market Cap
1.20B
Enterprise Value
1.27B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.92
Price/Book (mrq)
--
Enterprise Value/Revenue
2.05
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-97.10%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
703.03M
Net Income Avi to Common (ttm)
-1.08B
Diluted EPS (ttm)
-7.42
Balance Sheet and Cash Flow
Total Cash (mrq)
6.09M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--